Epiprobe ya biomarker ya pan-kanseri yakurikiranye “Siemens Healthcare” ya “Angel Project” i Wuwei

“Umumarayika Umushinga” ufasha mu kurwanya ubukene mu buvuzi.

Ku ya 19 Gashyantare 2023, Komite Nkuru y’Inama Ngishwanama ya Politiki y’Abashinwa (CPPCC) na Siemens bafatanyije gutangiza umushinga w’abamarayika Murinzi mu Ntara ya Gansu, batanga ibikoresho bigezweho ndetse banatanga ibikoresho by’ubuvuzi byujuje ubuziranenge mu karere kabo.Uyu mushinga wagize uruhare runini mu kuziba neza icyuho cy’ibikoresho byo gusuzuma no kuvura n’ikoranabuhanga ku nzego z’ibanze z’ibigo by’ubuvuzi byo ku rwego rw’intara, kunoza ubushobozi bwo gusuzuma no kuvura ibigo by’ubuvuzi by’ibanze, bikagabanya ibibazo byo gushaka kwivuza ku baturage .

Amahugurwa y’ubuvuzi yafunguwe hagamijwe kurushaho kunoza itsinda ry’abatekinisiye b’ubuvuzi n’urwego rwabo rwa tekiniki, ndetse no kongera ubushobozi bw’abakozi bo kwivuza no kurokora ubuzima.Mu ntambwe ikurikira, gahunda zose zamahugurwa zigamije kunoza imicungire yubuvuzi no gusuzuma no kuvura ubushobozi bizakorwa mu ntara zose.Epiprobe yakurikiranye "Umumarayika Umushinga" muri Wuwei, itanga ikoranabuhanga rishya ryo kumenya kanseri hamwe n'ibimenyetso bya kanseri byuzuye kugira ngo bikorere abaturage baho kandi bigire uruhare mu iterambere ry'inganda z'ubuvuzi n'ubuvuzi.

Epiprobe yakurikiranye "Umumarayika Umushinga" muri Wuwei.

Wuwei iherereye hagati mu Ntara ya Gansu mu majyaruguru y'uburengerazuba bw'Ubushinwa kandi ifite amateka maremare.Azwi nkumujyi wamateka numuco byigihugu.Nubwo, nubwo amateka akungahaye, urwego rwubuvuzi muri kariya gace rusigaye inyuma.Mu rwego rwo kunoza ibipimo by’ubuvuzi byaho no kurengera ubuzima bw’abaturage baho, Epiprobe yakurikiranye ubuvuzi bwa Siemens hamwe n’inama nyunguranabitekerezo ya politiki y’abaturage mu Bushinwa “Umushinga w’abamarayika” i Wuwei, itanga serivisi zo kumenya methylation.

Mu rwego rwo kuzamura urwego rwo kumenya kanseri y’ibitaro bya Wuwei, Epiprobe yafatanyije cyane n’ibitaro byaho gutanga amahugurwa y’ikoranabuhanga rya methylation, itanga abaganga baho uburyo bushya bwo gusuzuma kanseri hakiri kare, neza, kandi bunoze.

Ikimenyetso cya kanseri ya TAGMe® iherekeza ubuzima bwabagore baho.

Indwara ya kanseri yimyororokere ku bagore irakabije.Buri mwaka hamenyekana abagera ku 140.000 bashya ba kanseri y'inkondo y'umura na 80.000 bashya ba kanseri ya endometrale, baza ku mwanya wa mbere n'uwa kabiri muri kanseri y'imyororokere.Bitewe n'imbogamizi muburyo bwo gutahura, indwara nyinshi za kanseri y'inkondo y'umura na endometrale zirasuzumwa mugihe cyambere.

Nk’uko imibare y’ubushakashatsi ibigaragaza, imyaka itanu yo kubaho kwa kanseri y'inkondo y'umura igezweho ni 40% gusa.Niba isuzuma rishobora gukorwa mugihe cyabanjirije kanseri, igipimo cyo gukira gishobora kugera ku 100%, rwose ukagera ku ntego yo gukuraho kanseri y'inkondo y'umura no kurokora ubuzima bw'abantu benshi.

Mu rwego rwo gufasha abagore bo muri Wuwei kwirinda no kurwanya kanseri y'inkondo y'umura na endometrale, Epiprobe yakurikiranye ubuvuzi bwa Siemens hamwe na “Angel Project” ya Ligue iharanira demokarasi i Wuwei, izana ikoranabuhanga ryo kumenya methylation mu rwego rwo kurengera ubuzima bw'abagore baho.

Epiprobe yakoze biomarker idasanzwe ya pan-kanseri, TAGMe, hamwe na Me-qPCR idasaba ubuvuzi bwa metabisulfite, kugirango iteze imbere ibikoresho bya TAGMe ADN Methylation Detection Kits ya kanseri yimyororokere yumugore.Uburyo bukoreshwa muburyo bushobora gufasha abagore benshi kwirinda kanseri y'inkondo y'umura na endometinal.

Urugero rwa 1: Kwipimisha hakiri kare kanseri (gutahura hakiri kare ibikomere mbere ya kanseri)

Urugero rwa 2: Ibyago byinshi byabaturage HPV

Urugero rwa 3: Gusuzuma ubufasha bwabaturage bakekwa

Urugero rwa 4: Isuzuma ryibyago bisigaye nyuma yo kubagwa

Urugero rwa 5: Gukurikirana abaturage nyuma yo gukurikiranwa

Epiprobe yiyemeje gukunda no gukurikiza "Umushinga w'Abamarayika".Guhera kuri sitasiyo ya Wuwei, ikwirakwiza ubuvuzi kubantu benshi.